-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Pliant Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
- Pliant Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $10.6M, a 18.4% decline year-over-year.
- Pliant Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $39.8M, a 1.99% decline year-over-year.
- Pliant Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $44.5M, a 96.8% increase from 2022.
- Pliant Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $22.6M, a 117% increase from 2021.
- Pliant Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $10.4M, a 168% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)